标题/作者	年份
Aging, immunity, and COVID-19: how age influences the host immune response to coronavirus infections? V Bajaj, N Gadi, AP Spihlman, SC Wu, CH Choi, VR Moulton Frontiers in physiology 11, 571416	2021
Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 Cardiovascular Disease Registry NS Hendren, JA De Lemos, C Ayers, SR Das, A Rao, S Carter, ... Circulation 143 (2), 135-144	2021
Comorbidities in SARS-CoV-2 patients: a systematic review and meta-analysis WH Ng, T Tipih, NA Makoah, JG Vermeulen, D Goedhals, JB Sempa, ... MBio 12 (1), 10.1128/mbio. 03647-20	2021
Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection TI Hariyanto, A Kurniawan Obesity medicine 19, 100290	2020
Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral–bacterial interactions IL Kruglikov, M Shah, PE Scherer Elife 9, e61330	2020
The dynamic association between COVID-19 and chronic disorders: an updated insight into prevalence, mechanisms and therapeutic modalities SK Alyammahi, SM Abdin, DW Alhamad, SM Elgendy, AT Altell, HA Omar Infection, Genetics and Evolution 87, 104647	2021
Independent Role of Severe Obesity as a Risk Factor for COVID‐19 Hospitalization: A Spanish Population‐Based Cohort Study U Fresán, M Guevara, F Elía, E Albéniz, C Burgui, J Castilla, ... Obesity 29 (1), 29-37	2021
A meta-analysis of the association between obesity and COVID-19 J Yang, ZY Ma, YC Lei Epidemiology & Infection 149, e11	2021
SARS-CoV-2 and mitochondrial health: implications of lifestyle and ageing AVW Nunn, GW Guy, W Brysch, SW Botchway, W Frasch, EJ Calabrese, ... Immunity & Ageing 17 (1), 1-21	2020
Obesity and infectious diseases: pathophysiology and epidemiology of a double pandemic condition G Pugliese, A Liccardi, C Graziadio, L Barrea, G Muscogiuri, A Colao International Journal of Obesity 46 (3), 449-465	2022
Virus infections and host metabolism—can we manage the interactions? D Sumbria, E Berber, M Mathayan, BT Rouse Frontiers in immunology 11, 594963	2021
Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies G Pathangey, PP Fadadu, AR Hospodar, AE Abbas American Journal of Physiology-Lung Cellular and Molecular Physiology 320 (3 …	2021
COVID-19 severity in obesity: leptin and inflammatory cytokine interplay in the link between high morbidity and mortality R Maurya, P Sebastian, M Namdeo, M Devender, A Gertler Frontiers in immunology 12, 649359	2021
MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients D Carolina, AES Couto, LCB Campos, TF Vasconcelos, ... Biomedicine & Pharmacotherapy 142, 112067	2021
Pathways to severe COVID‐19 for people with obesity RW O’rourke, CN Lumeng Obesity 29 (4), 645-653	2021
Next-generation sequencing reveals the progression of COVID-19 X Chen, Y Kang, J Luo, K Pang, X Xu, J Wu, X Li, S Jin Frontiers in cellular and infection microbiology 11, 632490	2021
SOCS, intrinsic virulence factors, and treatment of COVID-19 HM Johnson, AS Lewin, CM Ahmed Frontiers in immunology 11, 582102	2020
Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans M Zickler, S Stanelle-Bertram, S Ehret, F Heinrich, P Lange, ... Cell metabolism 34 (1), 1-2	2022
SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages GJ Martínez-Colón, K Ratnasiri, H Chen, S Jiang, E Zanley, A Rustagi, ... Science Translational Medicine 14 (674), eabm9151	2022
Impact of obesity in critical illness MR Anderson, MGS Shashaty Chest 160 (6), 2135-2145	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。